α-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: A prospective study
- 1 April 2002
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 35 (4) , 853-860
Abstract
α-fetoprotein (AFP) messenger RNA (mRNA) has been proposed as a marker of hepatocellular carcinoma (HCC) cells disseminated into the circulation, but its clinical significance remains controversial. We prospectively assessed the prognostic value of AFP mRNA in patients undergoing curative hepatic resection for HCC. Peripheral blood samples were taken from 87 patients before and after surgery to determine the presence of AFP mRNA by use of a reverse-transcription polymerase chain reaction. A primary endpoint was recurrence-free interval. AFP mRNA was detectable preoperatively in 31 patients (36%) and postoperatively in 30 patients (34%). With a median follow-up period of 28 months (range, 3-41 months), HCC recurred in 46 patients (53%). Among 4 groups separated according to preoperative and postoperative AFP mRNA status, patients with consistent positivity of AFP mRNA showed the highest recurrence rate (85%) and trend to distant or multiple recurrence. The recurrence-free interval was significantly shorter in patients with postoperative positivity of AFP mRNA than in those without (53% [95% CI, 36-71] vs. 88% [95% CI, 79-96] at 1 year, 37% [95% CI, 17-57] vs. 60% [95% CI, 46-75] at 2 years; P = .014), whereas the preoperative positivity of AFP mRNA provided no significance (P = .100). Cox's proportional-hazards model identified the postoperative positivity of AFP mRNA as an independent prognostic factor for HCC recurrence (relative risk, 2.33; 95% CI, 1.26-4.34; P = .007). In conclusion, postsurgical recurrence of HCC can be predicted by detecting AFP mRNA-expressing cells in peripheral blood.Keywords
This publication has 32 references indexed in Scilit:
- Presence of α-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinomaJournal of Hepatology, 1999
- Liver Resection and Needle Liver Biopsy Cause Hematogenous Dissemination of Liver CellsHepatology, 1999
- Survival and Recurrence After Liver Transplantation Versus Liver Resection for Hepatocellular CarcinomaAnnals of Surgery, 1998
- Lack of specificity of albumin-mRNA-positive cells as a marker of circulating hepatoma cellsHepatology, 1997
- Hematogenous Spreading of Hepatocellular Carcinoma Cells: Possible Participation in Recurrence in the LiverHepatology, 1997
- Does surgery disseminate or accelerate cancer?The Lancet, 1995
- Risk factors for intrahepatic recurrence in human small hepatocellular carcinomaGastroenterology, 1995
- Detection of α-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: A possible predictor of metastatic hepatocellular carcinomaHepatology, 1994
- Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reactionThe Lancet, 1991
- Cancer Cells in the BloodAnnals of Surgery, 1959